FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ
FDA批准摘要:诺加潘地金α(Nogapendekin Alfa)联合卡介苗(BCG)治疗对卡介苗无反应的原位癌
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1231
Heiss, Brian L; Chang, Elaine; Joeng, Hee-Koung; Fiero, Mallorie H; Wang, Lingshan; Hamed, Salaheldin S; Chiu, Haw-Jyh; Ricks, Tiffany K; Koh, Eun Hee; Dellibovi-Ragheb, Teegan A; Wang, Min; Lee, Christal; Pierce, William F; Leighton, John K; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L